Large-cap stocks hold a special allure for savvy investors. Renowned for their stability and proven track records, they serve as a beacon of hope in the choppy seas of the stock market.
These stalwarts often reward shareholders with dividends, making them a bedrock for conservative investors seeking steady returns in uncertain times.
Three large-cap candidates shining brightly on the growth front are: Arista Networks, Target, and Cardinal Health.
Each of the trio boasts a favorable Zacks Rank, emblematic of upward earnings projections by analysts. Let’s delve deeper into each gem.
Arista Networks
Arista Networks has surfed the AI wave triumphantly. Its provision of network switches to hyperscalers has accelerated communication between computer servers, propelling the company to meteoric heights.
Draped with a Zacks Rank #2 (Buy), its growth prospects continue to ascend across all time frames.
Image Source: Zacks Investment Research
The company parades an impressive growth profile. Consensus estimates for its current fiscal year augur a 43% surge in earnings on the back of a 33% uptick in sales. The growth trajectory appears set to continue in FY24, with estimates signaling a further 10% earnings lift coupled with an 11% revenue climb.
Target
Target’s evolution from a brick-and-mortar retailer to an omni-channel powerhouse has charmed investors. Sporting a Zacks Rank #2 (Buy), its earnings estimates are scaling new heights.
The company’s profitability landscape is set to bloom, with consensus estimates painting a picture of 40% earnings growth in the current fiscal year. Not to mention, the stock offers a juicy dividend, currently yielding a market-beating 3.1%.
Target’s generosity toward its shareholders is evident in its robust 15% five-year annualized dividend growth rate.
Image Source: Zacks Investment Research
Cardinal Health
Cardinal Health, a national drug distributor and healthcare services provider, is in the spotlight with a Zacks Rank #2 (Buy). Its earnings revisions for the current fiscal year have surged by 12% over the past year.
Image Source: Zacks Investment Research
Consensus estimates for its current year signal a 20% earnings surge on the back of a 10% rise in sales. Moving to FY25, estimates suggest a further 12% earnings boost paired with an 8% revenue climb.
Cardinal Health has been delighting its stakeholders, outshining earnings and revenue expectations in each of its last five releases.
The Verdict
Top Large-Cap Stocks for Your Consideration
Understanding the Allure of Large-Cap Stocks
Large-cap stocks are a cornerstone of diversified investment portfolios. Known for their resilience and formidable performance records, these stocks are regarded as cornerstones of many a savvy investor’s collection.
Exploring Promising Options
For those seeking solid exposure to the large-cap segment, it’s worth contemplating three standout publicly-traded companies: Target (TGT), Cardinal Health (CAH), and Arista Networks (ANET). All three companies exhibit promising improvements in their earnings outlooks, making them compelling candidates for investment.
The Eager Search for Lucrative Opportunities
Investors have been on the quest for the ultimate stock that promises to double, an endeavor that has led to the identification of an obscure chemical company. This entity, which has experienced a 65% surge over the past year, offers an enticing prospect due to its undervaluation, escalating 2022 earnings projections, and earmarked $1.5 billion for share buybacks, inciting a potential rush by retail investors to join the fray.
This relatively unknown firm stands as a formidable challenger to other recent stars like Boston Beer Company, which catapulted up by a staggering +143.0% in a shade over nine months, and NVIDIA, which witnessed a remarkable ascent of +175.9% within a single year.
Parting Shot
When it comes to large-cap stocks, the potential for growth and stability are undeniably attractive considerations for both institutional and individual investors. As always, thorough due diligence and careful assessment of individual stock characteristics are key to making informed investment decisions.
To read this article on Zacks.com click here.
